Prevention of Retinal Non-perfusion in Central Retinal Vein Occlusion by Hydroxycarbamide Treatment.

NCT02957760 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Central Retinal Vein Occlusion, Non-Ischemic

Interventions

DRUG: Hydroxycarbamid

Sponsor

Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]